Cerecor Announces Positive Phase I Safety Data for CERC-801 in Healthy Volunteers
ROCKVILLE, Md., April 29, 2019 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in development and commercialization of treatments for rare and orphan diseases in pediatrics and neurology, announced …